重症痙縮に伴う睡眠障害と髄腔内バクロフェン療法による改善

重症痙縮6例(脳性麻痺,外傷,脳卒中)に髄腔内バクロフェン(ITB)療法を行い,術前後の痙縮をmodified Ashworth scale(mAS)で,睡眠時間をウェアラブル睡眠記録装置で測定した.mASスコアは2.85から2.31へ改善した.睡眠時間は7.5時間から8.8時間に,深睡眠時間は0.5時間から3.4時間に,それぞれ有意に延長した.痙縮患者は睡眠時間と深度が確保できていないことと,それらがITB療法によって改善したことが示された.ITB療法の調節にはmASと睡眠時間が指標になり得る....

Full description

Saved in:
Bibliographic Details
Published in小児の脳神経 Vol. 49; no. 1; pp. 13 - 17
Main Authors 野村, 貞宏, 井本, 浩哉, 藤井, 奈津美, 藤附, 駿輔, 石原, 秀行
Format Journal Article
LanguageJapanese
Published 一般社団法人 日本小児神経外科学会 2024
日本小児神経外科学会
Subjects
Online AccessGet full text
ISSN0387-8023
2435-824X
DOI10.34544/jspn.49.1_13

Cover

Abstract 重症痙縮6例(脳性麻痺,外傷,脳卒中)に髄腔内バクロフェン(ITB)療法を行い,術前後の痙縮をmodified Ashworth scale(mAS)で,睡眠時間をウェアラブル睡眠記録装置で測定した.mASスコアは2.85から2.31へ改善した.睡眠時間は7.5時間から8.8時間に,深睡眠時間は0.5時間から3.4時間に,それぞれ有意に延長した.痙縮患者は睡眠時間と深度が確保できていないことと,それらがITB療法によって改善したことが示された.ITB療法の調節にはmASと睡眠時間が指標になり得る.
AbstractList 重症痙縮6例(脳性麻痺,外傷,脳卒中)に髄腔内バクロフェン(ITB)療法を行い,術前後の痙縮をmodified Ashworth scale(mAS)で,睡眠時間をウェアラブル睡眠記録装置で測定した.mASスコアは2.85から2.31へ改善した.睡眠時間は7.5時間から8.8時間に,深睡眠時間は0.5時間から3.4時間に,それぞれ有意に延長した.痙縮患者は睡眠時間と深度が確保できていないことと,それらがITB療法によって改善したことが示された.ITB療法の調節にはmASと睡眠時間が指標になり得る.
「要旨」重症痙縮6例 (脳性麻痺, 外傷, 脳卒中) に髄腔内バクロフェン (ITB) 療法を行い, 術前後の痙縮をmodified Ashworth scale (mAS) で, 睡眠時間をウェアラブル睡眠記録装置で測定した. mASスコアは2.85から2.31へ改善した. 睡眠時間は7.5時間から8.8時間に, 深睡眠時間は0.5時間から3.4時間に, それぞれ有意に延長した. 痙縮患者は睡眠時間と深度が確保できていないことと, それらがITB療法によって改善したことが示された. ITB療法の調節にはmASと睡眠時間が指標になり得る.
Author 野村, 貞宏
石原, 秀行
藤井, 奈津美
井本, 浩哉
藤附, 駿輔
Author_xml – sequence: 1
  fullname: 野村, 貞宏
  organization: 山口大学医学部附属病院てんかんセンター
– sequence: 1
  fullname: 井本, 浩哉
  organization: 山口大学医学部附属病院てんかんセンター
– sequence: 1
  fullname: 藤井, 奈津美
  organization: 山口大学医学部附属病院てんかんセンター
– sequence: 1
  fullname: 藤附, 駿輔
  organization: 山口大学医学部附属病院てんかんセンター
– sequence: 1
  fullname: 石原, 秀行
  organization: 山口大学医学部脳神経外科
BookMark eNo9kEtLw0AUhQepYH0s_RmpM3MnyWThQsQXCG4quBum04kmtIkkunDZ1BeI4EItioKuFERd1IWC_2assf_C0IqLew7cy_kO3HFUiuJIIzRNcAWYzdhMmG5HFeZViCAwgsqUgW1xyjZKqIyBuxbHFMbQVJqGGGMAwhhnZVTtH53mnaO8c5W_v5jW09fnm2kd5rf3-c1d__qm99I1rcf-0_7PwXnv8MC0z0z2atrPpn1hsgfT7uZX2Xf3ogia7NhkJ9_nH73L_Uk06stGqqf-fAKtLy5U55et1bWllfm5VSukjs2tek0pl0lf217dJlTWfaWVdmucYuk6DoB0wfFcH9PijpXPMFPUppJ4NZCSY5hAS0NuU9cDJRtx1AgiLcJ4N4mKXqFimsYq0IJiygTGzMOkMCiGDMRlwMF2eEGaHZLCdEduarGdBE2Z7AmZ7ASqUSCL5wrmCTIQ-N-rLZmIUMIvA5uRWw
ContentType Journal Article
Copyright 2024 一般社団法人日本小児神経外科学会
Copyright_xml – notice: 2024 一般社団法人日本小児神経外科学会
CorporateAuthor 山口大学医学部附属病院てんかんセンター
山口大学医学部脳神経外科
CorporateAuthor_xml – name: 山口大学医学部脳神経外科
– name: 山口大学医学部附属病院てんかんセンター
DOI 10.34544/jspn.49.1_13
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
EISSN 2435-824X
EndPage 17
ExternalDocumentID co2socie_2024_004901_003_0013_00174383568
article_jspn_49_1_49_13_article_char_ja
GroupedDBID ABDBF
ABJNI
ALMA_UNASSIGNED_HOLDINGS
JSF
MOJWN
RJT
ID FETCH-LOGICAL-j2658-dbcc74afe59d512adfcece7b820a76633a73697f029d50cf404c252a19b3aa803
ISSN 0387-8023
IngestDate Thu Jul 10 16:10:11 EDT 2025
Wed Sep 03 06:31:10 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 1
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j2658-dbcc74afe59d512adfcece7b820a76633a73697f029d50cf404c252a19b3aa803
OpenAccessLink https://www.jstage.jst.go.jp/article/jspn/49/1/49_13/_article/-char/ja
PageCount 5
ParticipantIDs medicalonline_journals_co2socie_2024_004901_003_0013_00174383568
jstage_primary_article_jspn_49_1_49_13_article_char_ja
PublicationCentury 2000
PublicationDate 20240000
PublicationDateYYYYMMDD 2024-01-01
PublicationDate_xml – year: 2024
  text: 20240000
PublicationDecade 2020
PublicationTitle 小児の脳神経
PublicationTitleAlternate 小児の脳神経
PublicationYear 2024
Publisher 一般社団法人 日本小児神経外科学会
日本小児神経外科学会
Publisher_xml – name: 一般社団法人 日本小児神経外科学会
– name: 日本小児神経外科学会
References [1] Albright AL, Barron WB, Fasick MP, Polinko P, Janosky J: Continuous intrathecal baclofen infusion for spasticity of cerebral origin. JAMA 270: 2475-2477, 1993.
[22] Seshadri DR, Li RT, Voos JE, Rowbottom JR, Alfes CM, Zorman CA, Drummond CK: Wearable sensors for monitoring the physiological and biochemical profile of the athlete. NPJ Digit Med 2: 72, 2019.
[6] Brennan PM, Whittle IR: Intrathecal baclofen therapy for neurological disorders: a sound knowledge base but many challenges remain. Br J Neurosurg 22: 508-519, 2008.
[14] Kraus T, Gegenleitner K, Svehlik M, Novak M, Steinwender G, Singer G: Long-term therapy with intrathecal baclofen improves quality of life in children with severe spastic cerebral palsy. Eur J Paediatr Neurol 21: 565-569, 2017.
[15] Kulkarni S, Jadhav TS: Prevalence of sleep disorders in children with cerebral palsy; a questionnaire-based observational study. J Pediatr Neurosci 16: 269-272, 2021.
[25] Thompson AJ, Jarrett L, Lockley L, Marsden J, Stevenson VL: Clinical management of spasticity. J Neurol Neurosurg Psychiatry 76: 459-463, 2005.
[5] Boster AL, Adair RL, Gooch JL, Nelson ME, Toomer A, Urquidez J, Saulino M: Best practices for intrathecal baclofen therapy: dosing and long-term management. Neuromodulation 19: 623-631, 2016.
[4] Boman K: Effect of emotional stress on spasticity and rigidity. J Psychosom Res 15: 107-112, 1971.
[20] Sadowska M, Sarecka-Hujar B, Kopyta I: Cerebral palsy: current opinions on definition, epidemiology, risk factors, classification and treatment options. Neuropsychiatr Dis Treat 16: 1505-1518, 2020.
[2] Badaru UM, Hassan AM, Ahmad RY, Nuhu JM, Lawal IU: Prevalence, pattern and impact of sleep disturbance on quality of life and exercise participation among children with cerebral palsy in Kano city. Sleep Sci 14: 348-356, 2021.
[3] Bohannon RW, Smith MB: Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 67: 206-207, 1987.
[10] Hill CM, Parker RC, Allen P, Paul A, Padoa KA: Sleep quality and respiratory function in children with severe cerebral palsy using night-time postural equipment: a pilot study. Acta Paediatr 98: 1809-1814, 2009.
[23] Solaro C, Lunardi GL, Capello E, Inglese M, Messmer Uccelli M, Uccelli A, Mancardi GL: An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients. Neurology 51: 609-611, 1998.
[8] Fonseca P, Ross M, Cerny A, Anderer P, van Meulen F, Janssen H, Pijpers A, Dujardin S, van Hirtum P, van Gilst M, et al: A computationally efficient algorithm for wearable sleep staging in clinical populations. Sci Rep 13: 9182, 2023.
[9] Giurgiu M, Ketelhut S, Kubica C, Nissen R, Doster AK, Thron M, Timm I, Giurgiu V, Nigg CR, Woll A, et al: Assessment of 24-hour physical behaviour in adults via wearables: a systematic review of validation studies under laboratory conditions. Int J Behav Nutr Phys Act 20: 68, 2023.
[7] Carskadon M, Dement W: Normal human sleep: An overview. In: Kryger MH, Roth T, Dement WC(eds): Principles and Practice of Sleep Medicine 4th ed. Philadelphia, Elsevier Saunders, 2005, pp 13-23.
[16] Matre DA, Sinkjaer T, Svensson P, Arendt-Nielsen L: Experimental muscle pain increases the human stretch reflex. Pain 75: 331-339, 1998.
[17] Migovich M, Ullal A, Fu C, Peters SU, Sarkar N: Feasibility of wearable devices and machine learning for sleep classification in children with Rett syndrome: a pilot study. Digit Health 9: 20552076231191622, 2023.
[13] Kimoto Y, Oshino S, Tani N, Hosomi K, Khoo HM, Fujita Y, Miura S, Iwata T, Emura T, Matsuhashi T, et al: Characteristics of changes in intrathecal baclofen dosage over time due to causative disease. Neurol Med Chir(Tokyo), 2023(online ahead of print).
[24] Subotic-Kerry M, Werner-Seidler A, Corkish B, Batterham PJ, Sicouri G, Hudson J, Christensen H, O’Dea B, Li SH: Protocol for a randomised controlled trial evaluating the effect of a CBT-I smartphone application(Sleep Ninja(R))on insomnia symptoms in children. BMC Psychiatry 23: 684, 2023.
[18] Mohon RT, Sawyer K, Pickett K, Bothwell S, Brinton JT, Sobremonte-King M, DelRosso LM: Sleep-related breathing disorders associated with intrathecal baclofen therapy to treat patients with cerebral palsy: a cohort study and discussion. NeuroRehabilitation 48: 481-491, 2021.
[27] Xue B, Licis A, Boyd J, Hoyt CR, Ju YS: Validation of actigraphy for sleep measurement in children with cerebral palsy. Sleep Med 90: 65-73, 2022.
[19] Penn RD, Kroin JS: Intrathecal baclofen alleviates spinal cord spasticity. Lancet 1: 1078, 1984.
[11] Hornby TG, Tysseling-Mattiace VM, Benz EN, Schmit BD: Contribution of muscle afferents to prolonged flexion withdrawal reflexes in human spinal cord injury. J Neurophysiol 92: 3375-3384, 2004.
[12] Hutson JA, Snow L: Sleep assessments for children with severe cerebral palsy: a scoping review. Arch Rehabil Res Clin Transl 2: 100087, 2020.
[26] Whiting S, Buoncristiano M, Gelius P, Abu-Omar K, Pattison M, Hyska J, Duleva V, Music Milanovic S, Zamrazilova H, Hejgaard T, et al: Physical activity, screen time, and sleep duration of children aged 6-9 years in 25 countries: an analysis within the WHO European childhood obesity surveillance initiative(COSI)2015-2017. Obes Facts 14: 32-44, 2021.
[21] Sandella DE, O’Brien LM, Shank LK, Warschausky SA: Sleep and quality of life in children with cerebral palsy. Sleep Med 12: 252-256, 2011.
References_xml – reference: [9] Giurgiu M, Ketelhut S, Kubica C, Nissen R, Doster AK, Thron M, Timm I, Giurgiu V, Nigg CR, Woll A, et al: Assessment of 24-hour physical behaviour in adults via wearables: a systematic review of validation studies under laboratory conditions. Int J Behav Nutr Phys Act 20: 68, 2023.
– reference: [23] Solaro C, Lunardi GL, Capello E, Inglese M, Messmer Uccelli M, Uccelli A, Mancardi GL: An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients. Neurology 51: 609-611, 1998.
– reference: [5] Boster AL, Adair RL, Gooch JL, Nelson ME, Toomer A, Urquidez J, Saulino M: Best practices for intrathecal baclofen therapy: dosing and long-term management. Neuromodulation 19: 623-631, 2016.
– reference: [6] Brennan PM, Whittle IR: Intrathecal baclofen therapy for neurological disorders: a sound knowledge base but many challenges remain. Br J Neurosurg 22: 508-519, 2008.
– reference: [12] Hutson JA, Snow L: Sleep assessments for children with severe cerebral palsy: a scoping review. Arch Rehabil Res Clin Transl 2: 100087, 2020.
– reference: [24] Subotic-Kerry M, Werner-Seidler A, Corkish B, Batterham PJ, Sicouri G, Hudson J, Christensen H, O’Dea B, Li SH: Protocol for a randomised controlled trial evaluating the effect of a CBT-I smartphone application(Sleep Ninja(R))on insomnia symptoms in children. BMC Psychiatry 23: 684, 2023.
– reference: [1] Albright AL, Barron WB, Fasick MP, Polinko P, Janosky J: Continuous intrathecal baclofen infusion for spasticity of cerebral origin. JAMA 270: 2475-2477, 1993.
– reference: [14] Kraus T, Gegenleitner K, Svehlik M, Novak M, Steinwender G, Singer G: Long-term therapy with intrathecal baclofen improves quality of life in children with severe spastic cerebral palsy. Eur J Paediatr Neurol 21: 565-569, 2017.
– reference: [3] Bohannon RW, Smith MB: Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 67: 206-207, 1987.
– reference: [26] Whiting S, Buoncristiano M, Gelius P, Abu-Omar K, Pattison M, Hyska J, Duleva V, Music Milanovic S, Zamrazilova H, Hejgaard T, et al: Physical activity, screen time, and sleep duration of children aged 6-9 years in 25 countries: an analysis within the WHO European childhood obesity surveillance initiative(COSI)2015-2017. Obes Facts 14: 32-44, 2021.
– reference: [20] Sadowska M, Sarecka-Hujar B, Kopyta I: Cerebral palsy: current opinions on definition, epidemiology, risk factors, classification and treatment options. Neuropsychiatr Dis Treat 16: 1505-1518, 2020.
– reference: [19] Penn RD, Kroin JS: Intrathecal baclofen alleviates spinal cord spasticity. Lancet 1: 1078, 1984.
– reference: [21] Sandella DE, O’Brien LM, Shank LK, Warschausky SA: Sleep and quality of life in children with cerebral palsy. Sleep Med 12: 252-256, 2011.
– reference: [8] Fonseca P, Ross M, Cerny A, Anderer P, van Meulen F, Janssen H, Pijpers A, Dujardin S, van Hirtum P, van Gilst M, et al: A computationally efficient algorithm for wearable sleep staging in clinical populations. Sci Rep 13: 9182, 2023.
– reference: [4] Boman K: Effect of emotional stress on spasticity and rigidity. J Psychosom Res 15: 107-112, 1971.
– reference: [7] Carskadon M, Dement W: Normal human sleep: An overview. In: Kryger MH, Roth T, Dement WC(eds): Principles and Practice of Sleep Medicine 4th ed. Philadelphia, Elsevier Saunders, 2005, pp 13-23.
– reference: [11] Hornby TG, Tysseling-Mattiace VM, Benz EN, Schmit BD: Contribution of muscle afferents to prolonged flexion withdrawal reflexes in human spinal cord injury. J Neurophysiol 92: 3375-3384, 2004.
– reference: [10] Hill CM, Parker RC, Allen P, Paul A, Padoa KA: Sleep quality and respiratory function in children with severe cerebral palsy using night-time postural equipment: a pilot study. Acta Paediatr 98: 1809-1814, 2009.
– reference: [27] Xue B, Licis A, Boyd J, Hoyt CR, Ju YS: Validation of actigraphy for sleep measurement in children with cerebral palsy. Sleep Med 90: 65-73, 2022.
– reference: [16] Matre DA, Sinkjaer T, Svensson P, Arendt-Nielsen L: Experimental muscle pain increases the human stretch reflex. Pain 75: 331-339, 1998.
– reference: [18] Mohon RT, Sawyer K, Pickett K, Bothwell S, Brinton JT, Sobremonte-King M, DelRosso LM: Sleep-related breathing disorders associated with intrathecal baclofen therapy to treat patients with cerebral palsy: a cohort study and discussion. NeuroRehabilitation 48: 481-491, 2021.
– reference: [17] Migovich M, Ullal A, Fu C, Peters SU, Sarkar N: Feasibility of wearable devices and machine learning for sleep classification in children with Rett syndrome: a pilot study. Digit Health 9: 20552076231191622, 2023.
– reference: [25] Thompson AJ, Jarrett L, Lockley L, Marsden J, Stevenson VL: Clinical management of spasticity. J Neurol Neurosurg Psychiatry 76: 459-463, 2005.
– reference: [13] Kimoto Y, Oshino S, Tani N, Hosomi K, Khoo HM, Fujita Y, Miura S, Iwata T, Emura T, Matsuhashi T, et al: Characteristics of changes in intrathecal baclofen dosage over time due to causative disease. Neurol Med Chir(Tokyo), 2023(online ahead of print).
– reference: [22] Seshadri DR, Li RT, Voos JE, Rowbottom JR, Alfes CM, Zorman CA, Drummond CK: Wearable sensors for monitoring the physiological and biochemical profile of the athlete. NPJ Digit Med 2: 72, 2019.
– reference: [2] Badaru UM, Hassan AM, Ahmad RY, Nuhu JM, Lawal IU: Prevalence, pattern and impact of sleep disturbance on quality of life and exercise participation among children with cerebral palsy in Kano city. Sleep Sci 14: 348-356, 2021.
– reference: [15] Kulkarni S, Jadhav TS: Prevalence of sleep disorders in children with cerebral palsy; a questionnaire-based observational study. J Pediatr Neurosci 16: 269-272, 2021.
SSID ssj0003314484
ssib044760907
ssib000871981
ssib058494427
Score 2.3402617
Snippet 重症痙縮6例(脳性麻痺,外傷,脳卒中)に髄腔内バクロフェン(ITB)療法を行い,術前後の痙縮をmodified Ashworth...
「要旨」重症痙縮6例 (脳性麻痺, 外傷, 脳卒中) に髄腔内バクロフェン (ITB) 療法を行い, 術前後の痙縮をmodified Ashworth scale (mAS) で, 睡眠時間をウェアラブル睡眠記録装置で測定した. mASスコアは2.85から2.31へ改善した. 睡眠時間は7.5時間から8.8時間に,...
SourceID medicalonline
jstage
SourceType Publisher
StartPage 13
SubjectTerms baclofen
cerebral palsy
sleep
spasticity
Title 重症痙縮に伴う睡眠障害と髄腔内バクロフェン療法による改善
URI https://www.jstage.jst.go.jp/article/jspn/49/1/49_13/_article/-char/ja
http://mol.medicalonline.jp/en/journal/download?GoodsID=co2socie/2024/004901/003&name=0013-0017j
Volume 49
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 小児の脳神経, 2024, Vol.49(1), pp.13-17
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1Na9VAMJT2IogoKtYvenCPqUl2k-zixc17eRRBTy30FvJ5eGArtr1463v9EETw0FoqFfSkUKyHelDw38T22X_hzG7Sl5Yeai9h3uzszOxMkp3ZtzsxjAdpkaaOm8UmzN7UZH7BzMQqUpPGGSRiLPfsDM8OP33mTc2wJ7Pu7Mjoo8aupaXFZDJ9dea5kot4FXDgVzwl-x-ePWYKCIDBv3AFD8P1XD4moSCQzPM2CX0ifIQ1IAQCAScyJCGFaJHIgISMBC0SsArDPUXcJtJWQItICxkKiXDoYt-A1t05NgETDt054S4RDGmACcBIQ4mwFOAQ2akwsl03uXWTX2GQs9ITkKGHPysaraoi5rwGAqQBiYFAoQKEsmZUjcjAIryjVHJrTWw1fI46a3ESmkJlGSA7Xh6urRgqIW0ibLzvsGPgKHplCt4Z0gM_qfT1lNlamt5DtlJrCNLFkJ6jTyQbdlT0LuqDY_TQKQCjYiAoPKOjUKZiuqNAMwYdpWGL6K831ys3znDNVonjuJUFbcBRz1BxC9SYREAkbdhe6RZINRChbHU8vDPMe9qYajgMXYNNPhoRMXB3edWNJ2Rj0sFay1gUUMcHCudASG1yR--krWdNXWj2xNtBT4E2bQRT-lzu6WmaMpcxnKcXXsxNMjFpR3WnE5XPq-cqQrKIichWFxrVeDyXGHUhORpzfN92R40xGbSDTiO69W0xPFbNmO9ZYrjaAaG3YKwqgouBG6U2Y1wXnKusoKvyKn0fNrWFeLUL2RuW5bj8XP-jqivbNILT6avGlSqrnJBa5WvGSDe-bkwfrb8dbK0PtrYHP_fK5d0_v3-Uy2uDj58HO5-OPuwc7O2Xy1-Pdlf-rm4crK2W_Xdl73vZ_1b2N8vel7K_P9juHe5vQsey97rsvTnc-HXwfuWGMdMJp1tTZvURFbPrQHZhZkma-iwucldkENzHWZHmae4nEPnHPqQbNPapJ_zCcqDdSgtmMXh5O7EtEhrH3KI3jdG5-bn8ljEBsUhceFhfK8sYy9wkLawcbBo7TsIhDxg3PG2U6IWulBOd04PjxuMTRoyqd-xClM47OEnlET4_kdqmYGM5Y9yKqy4-llp2PX77orLvGJeQt15VvWuMLr5cyu9BnrGY3K_up38eD_F6
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E9%87%8D%E7%97%87%E7%97%99%E7%B8%AE%E3%81%AB%E4%BC%B4%E3%81%86%E7%9D%A1%E7%9C%A0%E9%9A%9C%E5%AE%B3%E3%81%A8%E9%AB%84%E8%85%94%E5%86%85%E3%83%90%E3%82%AF%E3%83%AD%E3%83%95%E3%82%A7%E3%83%B3%E7%99%82%E6%B3%95%E3%81%AB%E3%82%88%E3%82%8B%E6%94%B9%E5%96%84&rft.jtitle=%E5%B0%8F%E5%85%90%E3%81%AE%E8%84%B3%E7%A5%9E%E7%B5%8C&rft.au=%E9%87%8E%E6%9D%91%2C+%E8%B2%9E%E5%AE%8F&rft.au=%E4%BA%95%E6%9C%AC%2C+%E6%B5%A9%E5%93%89&rft.au=%E8%97%A4%E4%BA%95%2C+%E5%A5%88%E6%B4%A5%E7%BE%8E&rft.au=%E8%97%A4%E9%99%84%2C+%E9%A7%BF%E8%BC%94&rft.date=2024&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E5%B0%8F%E5%85%90%E7%A5%9E%E7%B5%8C%E5%A4%96%E7%A7%91%E5%AD%A6%E4%BC%9A&rft.issn=0387-8023&rft.eissn=2435-824X&rft.volume=49&rft.issue=1&rft.spage=13&rft.epage=17&rft_id=info:doi/10.34544%2Fjspn.49.1_13&rft.externalDocID=article_jspn_49_1_49_13_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0387-8023&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0387-8023&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0387-8023&client=summon